Bringing a tidal wave of change to solid tumor immunotherapy
TCE-based immunotherapy has the potential to make waves in solid tumor treatment.
Poseidon’s Trident platform holds the potential of better solutions for patients.
The Trident T-cell engager (TCE) platform technology is:
Modular
Conditionally activated
Optimized for tumor penetration and retention
Has as an improved safety profile due to reduced cytokine production
Privacy Policy
LinkedIn
